Skip to content

CADL - Candel Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Candel Therapeutics Inc

CADL · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CADLCandel Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $13.82
52-wk low: $4.35
Prev close: $9.39
Mkt cap: $1.03B
Fwd P/E: 43.5x
Beta: -0.50

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$221.0M

MI
Millennium
Israel Englander · Q2 2026 13F
$11.3M
position
MW
Marshall Wace

Earnings

Reported Aug 13, 2026

Earnings came in 59.1% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 43.48
Market cap: $1.0B

Valuation

P/S436.42
P/B7.31

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CADL
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.03B
Beta: -0.50

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

436.4x

P/B

7.3x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-81.8%

Q2 2026 13F

$3.1M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$1.5M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CADL

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.35-59.1%

-$0.22 expected

Next report

What the street expects next

EPS expected

-$0.31

-$0.33 to -$0.29

Revenue expected

$0.00

7 analysts

Estimate drift

0.06

Change in 30 days

-81.8%

ROA-28.6%

Growth

Beta-0.50